Drug Trial Radar · NCT05536804
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
134
Actual
Start
Feb 8, 2023
Primary completion
Jul 6, 2026
Study completion Jul 30, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 13, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or without type 2 diabetes (T2D). The study will last about 56 weeks and include up to 12 visits.
Conditions
- Overweight
- Obesity
- Chronic Kidney Disease
- Type 2 Diabetes
- T2D
Interventions
TirzepatideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Renal Sinus Fat Content (MRI)Time frame: Baseline, Week 52
Locations
27 sites in 6 countries. Site status is shown where the registry gives one.
Valley Clinical Trials, Inc.
Northridge, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Kidney Associates of Colorado
Denver, Colorado
American Health Network of Indiana, LLC - Avon
Avon, Indiana
American Health Network of Indiana, LLC - Greenfield
Greenfield, Indiana
Indiana University Health University Hospital
Indianapolis, Indiana
American Health Network of Indiana, LLC - Muncie
Muncie, Indiana
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan
University of Washington Medical Center - Montlake
Seattle, Washington
Providence Medical Research Center - Spokane
Spokane, Washington
Klinik Landstraße
Vienna, Austria
Zentrum für klinische Studien Dr Hanusch Gmbh
Vienna, Austria
Klinik Hietzing
Vienna, Austria
LMC Clinical Research Inc. (Barrie)
Barrie, Canada
LMC Clinical Research Inc. (Thornhill)
Concord, Canada
Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T
Sherbrooke, Canada
Toronto General Hospital
Toronto, Canada
Fadia El Boreky Medicine
Waterloo, Canada
Aarhus Universitetshospital, Skejby
Aarhus, Denmark
Centro de Investigación y Gastroenterología
Cuauhtémoc, Mexico
Investigación Nefrológica
Cuernavaca, Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
México, Mexico
Health Pharma Professional Research S.A. de C.V:
Mexico City, Mexico
Grupo Medico Camino Sc
Mexico City, Mexico
Caimed Investigacion En Salud S.A. de C.V.
Mexico City, Mexico
Ziekenhuisgroep Twente, locatie Almelo
Almelo, Netherlands
Amsterdam UMC, locatie VUmc
Amsterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.